Vedanta Biosciences

Vedanta Biosciences doses first subject in Phase III C difficile prevention trial
Clinical Trials Arena
Wed, 05/22/24 - 11:24 am
Vedanta Biosciences
clinical trials
VE303
C. difficile
Vedanta Raises $106.5M to Advance New Class of C.diff Therapeutics
BioSpace
Tue, 04/25/23 - 10:00 pm
Vedanta Biosciences
funding
C. difficile
VE303
Vedanta brings home a win for lead microbiome program, passing a PhII test and clinching BARDA investment
Endpoints
Tue, 10/5/21 - 10:54 am
Vedanta Biosciences
microbiome
clinical trials
C. difficile
BARDA
Pfizer invests $120M in 4 biotechs through new growth fund
Fierce Biotech
Tue, 01/12/21 - 10:56 am
Pfizer
funding
PBGI
Homology Medicines
Essa Pharma
Vedanta Biosciences
Trillium Therapeutics
PureTech’s Vedanta Biosciences gets federal funding for C. Diff. microbiome therapy
Pharmaforum
Wed, 09/30/20 - 11:03 pm
Vedanta Biosciences
microbiome
C. difficile
BARDA
Vedanta Biosciences initiates first-in-patient study of VE800 in combination with Bristol-Myers Squibb’s Opdivo
Pharmaceutical Business Review
Wed, 12/11/19 - 10:10 am
Vedanta Biosciences
VE800
Bristol-Myers Squibb
Opdivo
cancer
clinical trials
Vedanta Biosciences enrolls first patient in VE416 phase 1b/2 food allergy clinical study
Pharmaceutical Business Review
Tue, 07/2/19 - 11:46 am
Vedanta Biosciences
clinical trials
peanut allergy
VE416
Microbiome Report for Week Ending 5/18/19
Sun, 05/26/19 - 02:28 pm
microbiome
4D Pharma
Azitra
Vedanta Biosciences
Infant Bacterial Therapeutics
IBP-9414
SkinBio Therapeutics
Thetanix
Chron's Disease
Microbiome Report for Week Ending 5/11/19
CP Wire
Fri, 05/17/19 - 09:56 am
icrobiome
Vedanta Biosciences
MaaT Pharma
Acute GvHD
patents
Microbiome Report for Week Ending 5/11/19
Fri, 05/17/19 - 09:55 am
microbiome
Vedanta Biosciences
MaaT Pharma
Acute GvHD
patents
Microbiome upstart Vedanta gets an extra $18.5M in the bank, wrapping up $45.5 series C round
Endpoints
Mon, 05/13/19 - 10:03 am
microbiome
Vedanta Biosciences
VE303
Clostridium Difficile
Vedanta Biosciences Key Microbiome Patent Upheld in European Opposition Proceedings
CP Wire
Tue, 05/7/19 - 11:35 pm
Vedanta Biosciences
microbiome
patents
Vedanta Biosciences Key Microbiome Patent Upheld in European Opposition Proceedings
Tue, 05/7/19 - 11:28 pm
Vedanta Biosciences
microbiome
patents
Microbiome Report for Week Ending 1/26/19
CP Wire
Tue, 01/29/19 - 03:39 pm
microbiome
Second Genome
Vedanta Biosciences
NASH
Immune Biotech
Vedanta Biosciences Publishes Seminal Research in Leading Scientific Journal Regarding its Immuno-oncology Candidate, VE800
CP Wire
Thu, 01/24/19 - 10:46 am
Vedanta Biosciences
VE800
immuno-oncology
microbiome
Vedanta Biosciences Publishes Seminal Research in Leading Scientific Journal Regarding its Immuno-oncology Candidate, VE800
Thu, 01/24/19 - 12:19 am
Vedanta Biosciences
VE800
immuno-oncology
microbiome
Bristol-Myers Squibb and Vedanta Biosciences to Evaluate Opdivo and VE800 in Patients with Advanced or Metastatic Cancers
CP WIre
Mon, 12/10/18 - 11:35 pm
Bristol-Myers Squibb
Vedanta Biosciences
Opdivo
VE800
micro
Bristol-Myers Squibb and Vedanta Biosciences to Evaluate Opdivo and VE800 in Patients with Advanced or Metastatic Cancers
Mon, 12/10/18 - 11:34 pm
Bristol-Myers Squibb
Vedanta Biosciences
Opdivo
VE800
microbiome
Microbiome Report for Week Ending 12/1/18
CP Wire
Sat, 12/8/18 - 02:42 pm
microbiome
Evelo Biosciences
Kaleido Biosciences
Vedanta Biosciences
psoriasis
atopic dermatitis
IBD
Microbiome Report for Week Ending 12/1/18
Mon, 12/10/18 - 09:06 am
Evelo Biosciences
Kaleido Biosciences
Vedanta Biosciences
psoriasis
atopic dermatitis
IBD

Pages